TRACLEER

This brand name is authorized in Austria, Australia, Canada, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States

Active ingredients

The drug TRACLEER contains one active pharmaceutical ingredient (API):

1 Bosentan
UNII Q326023R30 - BOSENTAN

Bosentan is a dual endothelin receptor antagonist (ERA) with affinity for both endothelin A and B (ETA and ETB) receptors. Bosentan decreases both pulmonary and systemic vascular resistance resulting in increased cardiac output without increasing heart rate.

Read about Bosentan

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TRACLEER Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C02KX01 Bosentan C Cardiovascular system → C02 Antihypertensives → C02K Other antihypertensives → C02KX Antihypertensives for pulmonary arterial hypertension
Discover more medicines within C02KX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 12134P, 12139X, 12140Y, 12143D, 12145F, 12146G, 12148J, 12149K, 5618Q, 5619R, 6429J, 6430K
Country: CA Health Products and Food Branch Identifier(s): 02244981, 02244982
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 02461596, 02461604, 12555335, 12555341, 16799904, 17437089
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 29443-11-10, 29466-11-10
Country: EE Ravimiamet Identifier(s): 1207897, 1207909, 1207910, 1207921, 1207932, 1430637
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 02220002, 02220004
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 010804, 010826
Country: FR Base de données publique des médicaments Identifier(s): 61855918, 64186770, 65100183
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 47655, 47658
Country: HK Department of Health Drug Office Identifier(s): 51759, 51760
Country: IE Health Products Regulatory Authority Identifier(s): 88208, 88209
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4660, 4661
Country: IT Agenzia del Farmaco Identifier(s): 035609027, 035609041, 035609078, 035609080
Country: JP 医薬品医療機器総合機構 Identifier(s): 2190026F1022, 2190026X1028
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1031309, 1031310, 1031311, 1031312, 1031313, 1050606, 1081751, 1081752
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 096M2008
Country: NL Z-Index G-Standaard, PRK Identifier(s): 67369, 67377, 93548
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 11549, 11550
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100111848, 100115504, 100315120
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65304001, W65304002, W65304003, W65305001, W65305002
Country: SG Health Sciences Authority Identifier(s): 12541P, 12543P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 16933011, 16933012
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8697542090037, 8697542090044, 8699593095474, 8699593095481
Country: US FDA, National Drug Code Identifier(s): 66215-101, 66215-102, 66215-103

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.